ERA PerMed JTC 2018 - "Research Projects on Personalised Medicine - Smart combination of Pre-clinical and Clinical Research with data and ICT Solutions"


Announcement "closed"
Organization:
European Commission
Scope:
International
Start:
Internal deadline:
Official deadline:
Description:

Objectiu de la convocatòria


ERA PerMed is an ERA-Net Cofund, supported by 31 partners of 22 countries and cofunded by the European Commission. It aims to align national research strategies and funding activities, promote excellence, reinforce the competitiveness of European players in PM, and enhance the European collaboration with non-EU countries.

 

Característiques principals


The overall aim of the call is to fund projects showing clinical feasibility of PM in complex/multifactorial diseases as well as other diseases (such as monogenic, rare diseases and cancer). Feasibility is intended to mean the demonstration of significant and clinically relevant improvement of current diagnostics and/or therapeutics, based on improved understanding of underlying molecular mechanisms. Furthermore, applicants are expected to combine pre-clinical and/or clinical research with bio-informatics components to enable data quality on one side and the potential applicability for health care providers on the other side. This should be based on methods that are possible to use in and/or be further developed for clinical, general practice and public health settings. This should be based on methods that are possible to use in and/or be further developed for clinical, general practice and public health settings. This may involve validation of known biomarkers, interoperable data solutions and software for decision support for healthcare providers.

 

Requisits

Eligibility Criteria:

 

  • Only transnational projects shall be funded.
  • Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the cal (see list above)l. All three legal entities must be independent from each other.
  • The project coordinator must be eligible to be funded by his/her national/regional participating funding organisations.
  • The maximum number of partners per project at the pre-proposal stage is six. At the full-proposal stage, the consortium can be increased up to seven partners in total only by inclusion of a partner coming from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited for full- roposal submission.
  • Within one consortium, not more than two partners from the same country participating in the call will be accepted. For some funding agencies the maximum number of eligible partners that can be funded in one project is limited to one partner (see also "Guidelines for applicants" regarding individual funding rules).
  • Partners not eligible for funding by one of the organisations participating in this JTC (e.g. from non-funding countries or not fundable according to the national/regional regulations of the participating funding organisations) may participate in projects if they are able to secure their own funding.
  •  

     

    Joint research proposals may be submitted by applicants belonging to one of the following categories (according to national/regional regulations of the funding organizations, please see “Guidelines for applicants”):

    A. Academia (research teams working in universities, other higher education institutions) or research institutes;

    B. Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of medical doctors in the research teams is encouraged;

    C. (Industry) Private partners, e.g. SMEs15 (small and medium-size enterprises). We strongly encourage that the consortia submitting applications to this call include partners coming from different categories to follow the crosscutting/multidisciplinarity character of the call, allowing the integration of partners from different levels of the value chain.

    For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team member

     

    Dotació

    The Health Department – Generalitat de Catalunya, (DS-CAT), is the funding agency for Catalonian Organisations. Tentative initial funding commitment of the agency to this call is 500.000 euros for 3 years, to be distrubueted by the best ranked projects. The envisaged number of teams potentially funded with the tentative initial funding commitment is not defined.

    Durada
    3 years

     

    More info at http://www.erapermed.eu/joint-calls/

     

    “Jornada de presentació de la convocatòria ERA PerMed”, on 9th March at 11:30 h.

    Sala de les Palmeres, Pavelló Ave MariaDepartament de SalutTravessera de les Corts, 131-159. Barcelona,